HIV Archives
Dooley honored by Treatment Action Group
Dec. 15, 2022—Vanderbilt's Kelly Dooley, MD, PhD, MPH, recently received the Research in Action Award from the Treatment Action Group (TAG).
Study explores CVD risk for people with HIV
Nov. 10, 2022—A Vanderbilt study found that among people with HIV infection, three types of CD4+ T helper cells are associated with incident cardiovascular disease (CVD) that are not explained by CVD risk.
Study identifies key player in T cell “education”
Sep. 1, 2022—New Vanderbilt research could inform therapeutic strategies for enhancing thymic function when desired — such as during aging, recovery from radiation therapy or chemotherapy, or other conditions that reduce T cell output.
Blood test figures in cancer risk for people with HIV
Mar. 17, 2022—A Vanderbilt study found that, among adult patients with HIV, those who have lower counts of certain types of blood cells have a markedly higher risk of developing cancer.
Ahonkhai advances in national challenge to improve HIV care for Black men in Tennessee
Feb. 24, 2022—A Vanderbilt proposal to implement a novel strategy to use barbers and barbershops to improve HIV care outcomes for Black men with HIV in Middle Tennessee received early-stage funding from a challenge hosted by the U.S. Department of Health and Human Services’ Office of Minority Health.
Establishing HIV care in Tennessee
Jul. 13, 2021—Vanderbilt researchers find that heterosexually active Black males are the least likely to establish HIV care within one month of diagnosis and suggest that targeted interventions focus on this population.
Study finds dramatic gains in life expectancy for people with HIV in Latin America
Apr. 21, 2021—A research team from Vanderbilt University Medical Center and institutions across Latin America today reports what looks to be far the largest study to date of life expectancy for people living with HIV infection in low-income or middle-income countries.
HIV, diabetes and immune cells in fat
Mar. 18, 2021—In HIV-positive individuals with diabetes, immune cells in fat are more proinflammatory and cytotoxic and may represent a therapeutic target for diabetes.
Clinic helps prepare young HIV patients for adult care
Mar. 4, 2021—Adolescents and young adults living with HIV in Middle Tennessee are being ushered into adult care through a special transition clinic that focuses on adult skill-building and individualized therapy and discussions.
VUMC investigator expands HIV research into South Africa
Feb. 18, 2021—A Vanderbilt University Medical Center investigator is hoping to improve access to HIV testing in South Africa, where more than 7 million people are known to have the virus, by training traditional healers to perform the tests.
Key factors in HIV-1 replication
Feb. 8, 2021—HIV-1, the virus that causes AIDS, exploits inositol phosphates in T cells to aid its own assembly and maturation — suggesting that targeting inositol phosphate binding could inhibit HIV-1 replication.
HIV patients stay away after Nigerian clinic introduces fees
Dec. 10, 2020—Six years ago, in Nigeria, funding cutbacks for HIV treatment and the consequent introduction of patient fees were associated with sharp declines in new HIV clinic enrollments and patient adherence to antiretroviral therapy (ART).
